Introduction
Blood flow in the blood vessels is determined by various factors, such as vessel diameter, blood pressure, vascular network structure, viscosity, and the rheological properties of blood [1] . A previous study has investigated the effects of blood rheology to disturbances in the microcirculation, mainly on erythrocyte dynamics [2] . Subsequent studies have employed intravital microscopy in order to demonstrate the pivotal role of leukocytes in microcirculatory flow [3] . Leukocytes are likely to be involved in flow disturbances in the microcirculation of various organs under physiological and pathological conditions [4] .
Leukocytes also play a central role in the pathogenesis of the various inflammatory or noninflammatory diseases [4] [5] [6] [7] [8] . Accumulated leukocytes may produce various cytokines and proteases, resulting in enlargement of the inflammation, or they may function in the host defense against foreign bodies [9] . In the large vessels, leukocytes mainly flow along the central stream. Even in microvessels, leukocytes exhibit limited interactions with endothelial cells under physiological conditions. Leukocyte-endothelial interactions are essential for leukocyte recruitment in a targeted organ, and these interactions are elaborately regulated by a multi-step cascade involving various adhesion molecules [10] [11] [12] [13] . Many animal studies have been conducted using intravital microscopy, allowing us to study leukocyte-endothelial interactions in vivo, and these studies have contributed to our un derstanding of the delicate regulation of various organs [4] [5] [6] [7] [8] .
Previous studies have revealed the importance of leukocytes in various retinal diseases [14] ; however, leukocyte behavior in the retinal microcirculation could not be adequately studied due to the lack of appropriate methods. Scanning laser ophthalmoscopes can capture a series of confocal fundus images at a video rate, and, when combined with fluorescence dyes, they enable the evaluation of leukocyte-endothelial interactions in the retinal microcirculation [15] . Novel methodologies have been used to obtain an increasing body of information with regard to the mechanisms of leukocyte recruitment in the retina, choroid, and the vitreous cavity [16] . In this paper, we review various methodologies in the study of leukocyte-retinal endothelial interactions in vivo , and summarize the information obtained from previous experimental studies employing these methods.
Leukocyte-Endothelial Interactions

Adhesion Molecules
Leukocyte-endothelial interactions are elaborately regulated with the aid of adhesion molecules expressed by the leukocytes and endothelial cells of the retinal blood vessels [10, 13] . Selectins are a family of 3 carbohydrate-recognizing transmembrane molecules -E-selectin, P-selectin, and L-selectin. The former 2 are expressed on activated endothelial cells, and the latter is constitutively expressed on leukocytes. Integrins are ␣ ␤ -heterodimers that recognize extracellular matrix cell surface glycoproteins. All leukocytes express ␤ 2 integrins [Mac-1 (CD11b/CD18), LFA-1 (CD11a/CD18), p150, and p95 (CD11c/CD18)]. The ligands of the integrins expressed on the endothelial cell surface are ICAM-1, ICAM-2, and ICAM-3, which belong to the immunoglobulin superfamily.
Multistep Process of Leukocyte-Endothelial Interactions
In order that freely circulating leukocytes accumulate in the target tissue, they must interact with vascular endothelial cells. These interactions involve multiple steps (tethering, rolling, activation, firm adhesion, and transmigration), and are mainly observed in postcapillary venules but not in arterioles ( fig. 1 ) [10, 13, 17] .
In postcapillary venules, leukocytes tend to move closer to the endothelial surface than in the central bloodstream. This is caused by a passive rheological phenomenon. The first interaction between leukocytes and en- Multistep process of leukocyte-endothelial interactions. It is essential for freely circulating leukocytes to interact with endothelial cells in order to accumulate in the target tissue. These interactions consist of multiple steps such as tethering, rolling, activation, firm adhesion, and transmigration. Each step is regulated elaborately by various adhesion molecules expressed by the leukocytes and endothelial cells.
dothelial cells is termed tethering, which is mediated by selectins. This initial intermittent interaction reduces the speed of the circulating leukocyte and facilitates the subsequent step of rolling. Previous experimental studies using intravital microscopy have elucidated the mechanism of leukocyte rolling. Reduction in their flow speed following the initial intermittent interactions allows leukocytes to intimately interact with the endothelial cells. This step, termed rolling, is mediated by E-and P-selectins expressed on the activated endothelium. While leukocytes interact with the endothelial cells, they become activated by chemoattractants produced by the activated endothelial cells, such as interleukin-8 and platelet-activating factor. During rolling, some activated leukocytes firmly adhere to the endothelial cells with Mac-1 (CD11b/ CD18) and LFA-1 (CD11a/CD18). In this process, chemoattractant receptors are stimulated, making the cell more rigid and enabling it to migrate. The leukocytes that adhere to the endothelial cells then transmigrate into the tissue with PECAM-1 (CD31) and ␤ 2 integrins.
Methodology
Thus far, researchers have introduced various methods for investigating leukocyte-retinal endothelial interactions in vivo, and these methods have been applied to physiological and pathological conditions. However, all the methods suggested and implemented this far have limitations.
Fluorescence-Labeled Leukocyte Angiography
When fluorescein sodium is infused into the vein, circulating leukocytes are stained with fluorescein sodium. However, due to the intense fluorescence in the serum, it is difficult to detect the leukocytes [16] . To reduce the background fluorescence, isolated donor leukocytes that are labeled in vitro are infused to the recipients and studies with scanning laser ophthalmoscopy (SLO). Thus far, studies have used different fluorescence agents such as fluorescein sodium, fluoroisothiocyanate (FITC), cal cein-AM, and carboxyfluorescein diacetate (CFDA) for leukocyte labeling [18] . Since the absorption peak and emission wavelength of these agents are near to the corresponding values of fluorescein sodium, the originally equipped filters for fluorescein angiography can be used for the analysis.
Many studies have used fluorescein sodium for leukocyte labeling [19] [20] [21] [22] . Blood was first incubated with sodium fluorescein in vitro, following which it was centrifuged and the buffy coat containing leukocytes and platelets was separated. These labeled cells were then infused into recipient animals. SLO with an argon laser was used to visualize the labeled leukocytes circulating in the fundus, which enables the investigation of leukocyte-endothelial interactions in the retina. Since the safety of fluorescein sodium is well established, several investigators have used this dye for human studies [22] . This method poses a limitation as the labeled leukocytes are contaminated by many platelets that also are stained with fluorescein sodium. Moreover, the leukocytes may be activated during isolation or labeling, and such activated leukocytes may exhibit unphysiological behavior after infusion. Other investigators have used FITC or calcein-AM to label isolated leukocytes [23] [24] [25] . These dyes have only been used in animal studies and have not been used in human studies [26] . Calcein-AM is reported to be nontoxic and has no effect on cell adhesion [27] .
CFDA is another possible fluorescence agent for leukocyte labeling [28] . CFDA itself is not fluorescent but is converted to carboxyfluorescein by intracellular esterase, whose fluorescence properties are similar to those of fluorescein sodium. After CFDA is converted into carboxyfluorescein, the dye remains within the cell [29] . CFDA enables visualization of leukocytes in the retinal circulation for 1 30 min. However, the usage of CFDA is also limited to animal experiments.
Acridine Orange Digital Angiography
Acridine orange has been widely used as a fluorescence probe for nucleic acids in studies using histochemistry, flow cytometry, and cytochemistry. The dye emits green fluorescence when it binds with double-stranded nucleic acids (DNAs). The spectral properties of acridine orange-DNA complexes are almost similar to those of fluorescein sodium. Retinal images were generated by SLO with the aid of argon blue laser and a regular emission filter for fluorescein angiography. Following intravenous injection of acridine orange solution, leukocytes are selectively stained among circulating blood cells because only leukocytes have double-stranded DNA.
Leukocyte dynamics are recorded at the video rate and can be studied frame by frame. Because the nuclei of vascular endothelial cells are also stained, this method allows investigation of leukocyte-endothelial interactions along the retinal veins, such as rolling and firm adhesion in vivo ( fig. 2 ) [30] [31] [32] . In addition, 30 min after the infusion, the fluorescence of the circulation leukocytes and endothelial cells fades and only the leukocytes accumulated in the retinal microcirculation can be visualized ( fig. 3 ) The number of leukocytes peaked 24 h after reperfusion ( d ). Significant reduction in leukocyte accumulation was observed in tacrolimus-treated rats at 12 h ( e ) and 24 h ( f ) after reperfusion. This figure was previously published in Stroke [85] .
that acridine orange has carcinogenic effects and can only be used in experimental animals. In addition, it is suggested that acridine orange causes a proportion of neutrophils to spontaneously convert from rolling to immobilization mediated by ␤ 2-integrin [27] . Acridine orange may cause some functional changes in the leukocytes.
Leukocyte Angiography with Carboxyfluorescein Diacetate Succinimidyl Ester
Carboxyfluorescein diacetate succinimidyl ester (CFDASE) is another dye that can enable visualization of leukocyte-retinal endothelial interactions in vivo by intravenous infusion of the dye. Similar to CFDA, CFDASE itself is not a fluorescence compound, but is converted to CFDASE within the cells, and has fluorescence properties similar to fluorescein sodium [5] . After the infusion, circulating leukocytes and endothelial cells can be visualized using SLO [33] . Immediately after the infusion, the contrast of circulating leukocytes is not as strong as those stained with acridine orange. However, leukocytes that adhere to the retinal vessels can be visualized clearly after the fluorescein levels in the bloodstream have decreased ( fig. 4 ). This method is only applied to animal studies.
Intravital Microscopy
Intravital epifluorescence microscopy is widely used to study the hemodynamics of various organs. When this technique is used to investigate retinal microcirculation, it is necessary to cancel the strong refractivity of the cornea. Anesthetized mice were placed under the objective and then examined. The refractive power of the cornea was counteracted by placing a glass slide on a ring surrounding the globe [34, 35] . The head was supported so that the iris was in a plane perpendicular to the axis of illumination. Epi-illumination was delivered through dichroic filters on a mercury lamp. The extracted donor leukocytes and erythrocytes were labeled separately in vitro with fluorescence dyes with different spectral properties, such as FITC and rhodamine-6G. After the fluorescence-labeled blood cells were infused in the recipient mice, the movement of blood cells was visualized using intravital microscopy. An intravital microscope can be equipped with multiple filters and strong illumination, so that switching the filter will facilitate concomitant visualization of elements labeled differently, thus permitting the simultaneous evaluation of leukocyte and erythrocyte movement.
Blue Field Simulation Technique
The blue field entoptic phenomenon is the perception of entoptic images observed against a bright blue illumination and is caused by the movement of leukocytes in the macular capillaries of the observer [36, 37] . Previous studies have noninvasively evaluated the velocity of leukocytes and the hemodynamics of retinal capillaries by matching the subject's entoptic images with the leukocyte motion simulated on a computer screen. This noninvasive method can be applied to human studies [38, 39] ; however, it is limited to the perifoveal capillary network and is subjective. It is impossible to study the behavior of each leukocyte.
Adaptive Optics AO-SLO
Adaptive optics SLO (AO-SLO) is an SLO-equipped adaptive optics technology that generates high-resolution and high-contrast retinal images by correcting ocular aberrations [40] [41] [42] . Recent studies have used AO-SLO to visualize individual retinal photoreceptors [43] . In addition, the videos obtained by AO-SLO can be used to noninvasively observe leukocyte movement in parafoveal Leukocyte angiography with CFDASE. a CFDASE fundus image of a rat with diabetes (40° field setting) shows that leukocytes adhere not only to venules (long arrow) but also to arterioles (short arrows). b The same fundus image in a 20° field setting. While many leukocytes were seen to flow through the retinal vessels (long arrows), 2 adhered to the walls of retinal arterioles (short arrows). The direction of the blood flow was used to distinguish arterioles from venules. This figure was previously published in The FASEB Journal [33] .
capillaries, which can be visualized as high-intensity particles moving in the dark vessels [44] [45] [46] . A frame-byframe analysis aids in evaluating the precise movement of each leukocyte. The results can be interpreted as follows: leukocytes circulating within the parafoveal capillaries allow the laser to penetrate and reach the photoreceptors beneath the vessels, facilitating detection of the reflected light from the photoreceptors at locations corresponding to the presence of leukocytes ( fig. 5 ). This method is similar to the blue field simulation technique [37] . The evaluation is limited to the parafoveal capillaries. However, this method enables objective analysis of the movement of each leukocyte in the retinal vessels, and it can also be applied to human studies. Thus far, the applications of this method, which has so far only been used in normal subjects, are expected to expand to various pathological conditions. Further, this method can potentially contribute to the study of leukocyte dynamics in the human retina.
Lectin Labeling of Adherent Leukocytes in the Retina
It is impossible to evaluate leukocyte movement in histological specimens of the retina; however, leukocytes that adhere to the retinal vessel can be studied [14, 47] . Concanavalin A lectin was used to label adherent leukocytes and vascular endothelial cells. After perfusion with phosphate-buffered saline to remove erythrocytes and non-adherent leukocytes, the experimental animals were fixed with paraformaldehyde and glutaraldehyde and stained with rhodamine-or FITC-coupled concanavalin A [33, 48, 49] . The retina was carefully removed, and flat mounts were prepared. The adherent leukocytes were observed under a fluorescence microscope ( fig. 6 ). 
Leukocyte-Endothelial Interactions in Pathological Conditions
Physiological Conditions
Nishiwaki et al. [30] used acridine orange leukocyte angiography and reported the behavior of each leukocyte in the physiological retina of monkeys. Although each leukocyte flows freely in retinal veins, some exhibit plugging in the retinal capillaries. Under physiological conditions, only few leukocyte-endothelial interactions were present; further, there were no rolling leukocytes in the main retinal arteries and veins. While the reason for this is unclear, organ specificity might explain the limited leukocyte-cell interactions. Alternatively, since the blood pressure within the retinal vein is relatively high in order to resist intraocular pressure, the difference in the blood pressure between the intraocular and extraocular veins could contribute to the increased shear stress in the retinal veins, resulting in less frequent interactions. In another paper, Nishiwaki et al. obtained images of the leukocyte movement in the murine retina at higher magnification [31] . Each leukocyte flowed in the capillaries with a deformation of shape [32] .
Diabetes Mellitus
There is increasing evidence suggesting the role of leukocytes in the pathogenesis of diabetic retinopathy [50] . McLeod et al. [47] studied patients with diabetes and reported elevated neutrophil levels in retinal vessels, together with elevated ICAM-1 expression. Persistent lowgrade inflammation from the upregulation of cytokines and other inflammatory mediators, and mechanical blockage of retinal capillaries due to plugged leukocytes are considered to contribute to the damage of retinal endothelial cells [51, 52] .
It has been reported that the nature of leukocytes itself is changed in patients with diabetes. In diabetes, the deformability and membrane fluidity of leukocytes are reported to be decreased [53] . In addition, more protein molecules are adsorbed on the surfaces of leukocyte membranes by glycosylation, resulting in decreased cell deformability [54] . These changes in the rigidity of leukocytes contribute to leukocyte plugging in the retinal capillaries as observed in experimental animals with diabetes [55] . In addition, leukocytes of individuals with diabetes show greater ability to adhere to the vascular endothelium [56] . In conditions of hyperglycemia, neutrophils exhibit increased adhesion to retinal endothelial cells [57, 58] .
Miyamoto et al. [59] reported increased leukostasis in both streptozotocin-induced diabetic rats and spontaneously diabetic Otsuka Long-Evans Tokushima Fatty rats. In the former case, increased retinal leukostasis was observed as early as 3 days after the induction of diabetes [60] . In addition, increased leukostasis was accompanied by a corresponding increase in leakage from the retinal vasculature. Fluorescein angiography revealed that these leukocytes were correlated with blockage of capillaries, resulting in local retinal non-perfusion. In these rats, increased leukostasis was accompanied by an upregulated expression of retinal ICAM-1 mRNA [60] . Moreover, the increases in leukostasis and in vascular permeability were inhibited by systemic administration of anti-ICAM-1 antibody [60] . These results indicate that the elevation of ICAM-1 on retinal endothelial cells may be essential for the retinal changes observed in early diabetes [50, 51] .
Another study has reported that leukocytes of patients with diabetes express higher levels of the ␣ -integrin subunits CD11a and CD11b and the ␤ -integrin subunit CD18 [61] . In addition, administration of anti-CD18 or anti-ICAM-1 antibodies was found to inhibit retinal leukostasis, in parallel with reduction of endothelial cell apoptosis [33, 62] . One study performed using CD18 or ICAM-1 knockout mice found that leukocyte adhesion in retinal vessels due to diabetes mellitus was substantially reduced with reduction in endothelial injury and breakdown of the blood-retinal barrier [63] .
Based on these findings, it can be said that chronic hyperglycemia due to diabetes causes increased ICAM-1 and integrin expression on retinal endothelial cells and leukocytes, respectively, leading to increased leukostasis in the retinal microvessels [51] . The increased leukocytes would contribute to the endothelial cell damage with increased leakage. These leukocyte-endothelial interactions may be a possible target of inhibition in diabetic retinopathy [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] .
Ischemia-Reperfusion Injury
After transient ischemia, leukocytes accumulate in the reperfused tissue and cause tissue injury by blocking the blood flow or by producing hydrogen peroxide [9, 79] . Tsujikawa et al. [80] studied the leukocyte-endothelial interaction after transient retinal ischemia. After ischemia was induced for 60 min, rolling leukocytes were first observed along the venous walls at 4 h after reperfusion. The number of rolling leukocytes increased and peaked at 12 h, and decreased to control levels at 96 h. Subsequent leukocyte accumulation increased with time and peaked at 24 h.
Nishijima et al. [81] have reported that the P-selectin and ICAM-1 gene expression levels in the retina after 60 min of ischemia were upregulated at 12 and 24 h after reperfusion. In addition, attenuation of P-selectin or ICAM-1 by systemic administration of monoclonal antibodies successfully reduced the leukocyte-endothelial interactions in the postischemic retina, consequently suppressing tissue damage [82] . On the basis of the results of these experiments, many investigators have studied various agents that can attenuate tissue damage by suppressing leukocyte-endothelial interactions in the postischemic retina. Antithrombin III [83, 84] , tacrolimus (FK506) [85] , argatroban (direct thrombin inhibitor) [86] , statin [87, 88] , Rho-associated protein kinase inhibitor [89] , superoxide dismutase [90] , thalidomide [91] , selectin ligands/inhibitor (SKK-60060) [92] , triamcinolone acetonide [93] , ischemic preconditioning [94, 95] , platelet depression [81] , and 17 ␤ -estradiol [96] are reported to reduce leukocyte accumulation in the postischemic retina and thereby reduce neural damage.
However, the time course of leukocyte-endothelial interactions in the postischemic retina considerably differs from that in other organs. Similar studies in the dorsal skinfold chamber model of hamsters, in mice, and in the mesentery of rats have reported that rolling leukocytes peak 30 min after reperfusion and almost subside 24 h after reperfusion [8] . This difference could be attributed to the specificity of the retina subjected to ischemia reperfusion injury [7] .
Macular Edema
Sometimes physicians encounter cases of macular edema after panretinal photocoagulation for diabetic retinopathy. Leukocyte velocities in the retinal capillaries were reported to have significantly decreased immediately after photocoagulation [97] . Nonaka et al. [98] hypothesized that inflammatory reactions after photocoagulation may be involved in the pathogenesis of macular edema, and they studied leukocyte-endothelial cell interactions and vascular permeability after partial scatter laser photocoagulation. Scatter laser photocoagulation caused significant inflammatory leukocyte-endothelial interactions not only in the photocoagulated but also in the untreated retina. In the nonphotocoagulated retina, the number of leukocytes rolling along the major retinal veins increased after photocoagulation and peaked at 12 h. Leukocyte accumulation in the untreated half of the retina increased and peaked at 24 h. In addition, the expressions of P-selectin and ICAM-1 genes were significantly upregulated [99] . These leukocyte-endothelial interactions were attenuated with posterior sub-tenon administration of triamcinolone acetonide [100] or systemic administration of thrombin inhibitor [99] . The inhibitory effect of triamcinolone acetonide on the macular edema after photocoagulation is consistent with clinical observations [101] .
Interferon-Associated Retinopathy
Guyer et al. [102] described interferon-associated retinopathy, which produces focal retinal ischemia, such as cotton-wool spots, capillary nonperfusion, and inner retinal hemorrhage. While the pathogenesis of interferon-associated retinopathy is unclear, diabetes mellitus, hypertension, retinal arterial sclerosis, and anemia were reported to be risk factors. Its fundus manifestation is similar to Purtscher's retinopathy, which is thought to be caused by retinal circular disturbances induced by activated leukocytes [103] . Nishiwaki et al. [104] reported adherent leukocytes and leukocytes rolling on the retinal venous wall in interferon ␣ -2b-treated rats. Leukocytes trapped in the retinal microcirculation were increased dose-dependently by intravenous administration of interferon ␣ -2b. In another report, interferon-␣ -induced leukocyte entrapment in retinal microcirculation was reduced by simultaneous administration with prednisolone, platelet-activating factor receptor antagonist, or superoxide dismutase [105] . Leukocytes stimulated with interferons may exhibit active interactions with retinal capillaries of veins, resulting in focal retinal ischemia.
Uveitis
Endotoxin-induced uveitis (EIU) is induced by injection of lipopolysaccharides derived from Gram-negative bacteria into footpads of experimental animals, and is frequently used to generate experimental models of uveitis. Miyamoto et al. [106] have studied the leukocyte-endothelial interactions in the retinae of EIU rats. In arteries and veins, EIU-induced vasodilatation gradually occurred and increased to the maximum level at 24 h. Leukocytes began to roll along the venous walls at 4.5 h after LPS injection and reached peaked at 12 h. Leukocytes were observed to infiltrate the vitreous cavity from 24 h after induction and peaked at 48 h. In parallel with the leukocyte rolling, the gene expression levels of P-selectin increased in the retina of EIU rats [107] . Moreover, administration of monoclonal antibodies to P-selectin at EIU induction successfully reduced the flux of leukocyte rolling and subsequent infiltration into the vitreous cavity. However, when P-selectin was inhibited after the induction, the leukocyte infiltration and inflammatory vasodilatation was not suppressed. Suzuma et al. [108] as-sayed the levels of E-selectin gene expression in the retina of EIU rats. Selective inhibition of E-selectin significantly blocked cellular infiltration into the aqueous humor; further, inhibition of both P-and E-selectin almost abrogated cellular infiltration. Based on these experiments, many investigators studied agents that could suppress leukocyte-endothelial interactions in uveitis. Selectin inhibitor [109] , TNF-␣ inhibitor [110] , diphenhydramine (histamine H1 receptor) [111] , and antithrombin III [112] were found to reduce leukocyte-endothelial interactions in the retinal veins in EIU rats. Hamada et al. [113] reported leukocyte behavior in the retina in experimental autoimmune uveoretinitis (EAU) [114] . Various uveitis models have been used to obtain increasing information on the molecular regulation of leukocyte recruitment [115] . Leukocyte-retinal endothelial interactions during uveitis are elaborately regulated by several adhesion molecules, cytokines, and chemokines [116] [117] [118] [119] [120] [121] [122] . Reviews of recent studies would aid in further elucidating these mechanisms [123] [124] [125] .
Conclusion
In nature, leukocyte behavior can be easily examined in the retina in vivo because the optical media is transparent. SLO substantially contributes to visualizing leukocyte-endothelial interactions in retinal vessels. However, most of the methods that employ SLO could only be used for animal studies. In addition, SLO is no longer commercially available. Recently, some investigators developed AO-SLO for the observation of retinal blood flow. AO-SLO noninvasively demonstrates the movement of each leukocyte in the parafoveal capillaries in humans. Thus far, AO-SLO has been applied only for investigating leukocyte movement in the retinae of normal subjects. However, it might contribute to our understanding of the leukocyte-retinal endothelial interactions in various diseases in humans.
